advanceCOR GmbH

We are a biotech company that independently develops innovative drugs and diagnostics for personalised treatment of cardiovascular diseases. We have a unique product pipeline that we are consistently moving into clinical trials. Our lead compound has recently been successfully tested in two Phase II studies. We work closely with academic teams in basic and clinical research. We use state-of-the-art analytical methods and develop our products according to the highest quality standards (GLP, GMP and GCP).